Skip to main content
SpringerLink
Log in

Cardiac effects of angiotensin converting enzyme inhibitors

  • Focused Section: Angiotensin Converting Enzyme Inhibition: Renal Aspects
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

ACE inhibitors have provided a major advance in cardiovascular therapeutics. The rationale for their use in hypertension and heart failure, and their cardiac effects are well documented. Further information is required on the relevance of their direct myocardial and other tissue effects, and it is likely that their use in hypertension and heart failure will increase further over the next several years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vidt DG, Bravo EL, Fouad FM. Captopril.N Engl J Med 1982;306:214–219.

    PubMed  Google Scholar 

  2. Todd PA, Heel RC. Enalapril: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs 1986; 31:198–248.

    PubMed  Google Scholar 

  3. Guidicelli JF, Berdeaux A, Edouard A, Richer C, Jacolot D. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.Br J Clin Pharmacol 1985; 20:211–218.

    PubMed  Google Scholar 

  4. Ajayi AA, Campbell BC, Meredith PA, Kelman AW, Reid JL. The effect of captopril on the reflex control of heart rate: Possible mechanisms.Br J Clin Pharmacol 1985;20:17–25.

    PubMed  Google Scholar 

  5. Tarazi RC, Bravo EL, Fouad FM, Omvik P, Cody RJ. Hemodynamic and plasma volume changes associated with captopril.Hypertension 1980;2:576–585.

    PubMed  Google Scholar 

  6. Fouad FM, Tarazi RC, Bravo EL. Cardiac and hemodynamic effects of enalapril.J Hypertens 1983;1 (Suppl 1):135–141.

    Google Scholar 

  7. Lombardo M, Zaini G, Pastori F, Fusco M, Pacini S, Foppoli C. Left ventricular mass and function before and after antihypertensive treatment.J Hypertens 1983;1:215–219.

    PubMed  Google Scholar 

  8. Dunn FC, Oigman W, Ventura HO, Messerli PH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.Am J Cardiol 1984;53:105–108.

    PubMed  Google Scholar 

  9. Fouad-Tarazi FM, Liebson PR. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.Hypertension 1987;9 (Suppl II):65–68.

    Google Scholar 

  10. Re RN. Cellular mechanisms of hypertrophy and hyperplasia: An emerging paradigm for cardiovascular research and intervention. In: Sonnenblick EH, Laragh JH, Lesch M, eds.New Frontiers in Cardiovascular Therapy: Focus on Angiotensin Converting Enzyme Inhibition. Excerpta Medica 1989:141–150.

  11. Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK. Sustained effectiveness of converting enzyme inhibition in patients with severe congestive heart failure.N Engl J Med 1980;302:1373–1379.

    PubMed  Google Scholar 

  12. Levine TB, Franciosa JA, Cohn JN. Acute and long-term response to an oral converting-enzyme inhibitor, captopril. in congestive heart failure.Circulation 1980;62:35–41.

    PubMed  Google Scholar 

  13. Ader R, Chatterjee K, Ports T, Brundage B, Hiramatsu B, Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation 1980;61: 931–937.

    PubMed  Google Scholar 

  14. Sharpe DN, Coxon RJ, Douglas JE, Long B. Low-dose captopril in chronic heart failure: Acute haemodynamic effects and long-term treatment.Lancet 1980;2:1154–1157.

    PubMed  Google Scholar 

  15. Captopril Multicenter Research Group: A placebo-controlled trial of captopril in refractory chronic congestive heart failure.J Am Coll Cardiol 1983;2:755–763.

    Google Scholar 

  16. Cody RJ, Covit AB, Schaer GL, Laragh JH. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.J Am Coll Cardiol 1983;1:1154–1159.

    PubMed  Google Scholar 

  17. DiCarlo L, Chatterjee K, Parmley WW, Swedberg K, Atherton B, Curran D, Cucci M. Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic haemodynamic evaluations.J Am Coll Cardiol 1983;2:865–871.

    PubMed  Google Scholar 

  18. Levine TB, Olivari MT, Garberg V, Sharkey SW, Cohn JN. Hemodynamic and clinical response to enalapril, a long acting converting-enzyme inhibitor, in patients with congestive heart failure.Circulation 1984;69:548–553.

    PubMed  Google Scholar 

  19. Sharpe DN, Murphy J, Coxon R, Hannan SF. Enalapril in chronic heart failure: A placebo-controlled, randomised, double-blind study.Circulation 1984;70:271–278.

    PubMed  Google Scholar 

  20. Packer M, Medina N, Yushak M. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.J Am Coll Cardiol 1984;3:1035–1043.

    PubMed  Google Scholar 

  21. Packer M, Medina N, Yushak M, Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.Circulation 1983;68:803–812.

    PubMed  Google Scholar 

  22. Franciosa JA, Dunkman B, Leddy CL. Hemodynamic effects of vasodilators and long-term response in heart failure.J Am Coll Cardiol 1984;3:1035–1043.

    PubMed  Google Scholar 

  23. Packer M, Medina N, Yushak M. Contrasting hemodynamic responses in severe heart failure: Comparison of captopril and other vasodilator drugs.Am Heart J 1982;104:1215–1223.

    PubMed  Google Scholar 

  24. Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.Am J Cardiol 1982;50:967–972.

    PubMed  Google Scholar 

  25. Chatterjee K, Rouleau JL, Parmley WW. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.Br Heart J 1982;47:233–238.

    PubMed  Google Scholar 

  26. Cleland JGF, Dargie HJ, Hodsman GP, Ball SGF, Robertson JIS, Morton JJ, East BW, Robertson I, Murray GD, Gillen G. Captopril in heart failure: A double-blind controlled trial.Br Heart J 1984;52:530–535.

    PubMed  Google Scholar 

  27. Cleland JGF, Dargie HJ, Hodsman GP, Ball SGF, Robertson JIS, Morton JJ, East BW, Robertson I, Murray GD, Gillen G. A controlled trial of enalapril in cardiac failure.Br Heart J 1985;54:305–312.

    PubMed  Google Scholar 

  28. Cleland JGF, Dargie HJ, Gillen G, Hodsman GP, Ball SG, Robertson JIS. Effects of enalapril on clinical state and serum electrolytes in congestive heart failure.Br J Clin Pharmacol 1985;19:542P–548P.

    Google Scholar 

  29. Webster MWI, Fitzpatrick MA, Nicholls MG, Ikram H, Wells JE. Effect of enalapril on ventricular arrhythmias in congestive heart failure.Am J Cardiol 1985;56:566–569.

    PubMed  Google Scholar 

  30. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure.N Engl J Med 1987;316:1429–1435.

    Google Scholar 

  31. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: Recognition by 2-dimensional echocardiography.N Engl J Med 1979;300:57–62.

    PubMed  Google Scholar 

  32. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: A 2-dimensional echocardiographic study.Am J Cardiol 1982;49:1120–1126.

    PubMed  Google Scholar 

  33. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation 1987;76:44–51.

    PubMed  Google Scholar 

  34. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction; the Framingham Study.Am J Cardiol 1979;44:53–59.

    PubMed  Google Scholar 

  35. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Cire Res 1985;57:84–95.

    Google Scholar 

  36. Pfeffer MA, Pfeffer JM, Steinbert C, Finn P. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril.Circulation 1985;72:406–412.

    PubMed  Google Scholar 

  37. Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.Lancet 1988;1:255–259.

    PubMed  Google Scholar 

  38. Daly P, Mettauer B, Rouleau JL, Cousineau D, Burgess JH. Lack of reflex increase in myocardial sympathetic tone after captopril: Potential antianginal effect.Circulation 1985;71: 317–325.

    PubMed  Google Scholar 

  39. Magrini F, Shimize M, Roberts N, Fouad FM, Tarazi RC, Zanchetti A. Converting-enzyme inhibition and coronary blood flow.Circulation 1987;75 (Suppl 1):1168–1174.

    Google Scholar 

  40. Dzau VJ, Re RN. Evidence for the existence of renin in the heart.Circulation 1987;75 (Suppl 1):1134–1136.

    Google Scholar 

  41. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology.Am J Cardiol 1987;59:59A–65A.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Auckland School of Medicine, Auckland, New Zealand

    Norman Sharpe MD, FRACP, FACC

Authors
  1. Norman Sharpe MD, FRACP, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharpe, N. Cardiac effects of angiotensin converting enzyme inhibitors. Cardiovasc Drug Ther 4, 243–245 (1990). https://doi.org/10.1007/BF01857639

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857639

Key Words

Search

Navigation